Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | May 15, 2024 | 0.68 | -9.09 |
T-Mobile US | TMUS | May 15, 2024 | 162.68 | +0.17 |
T. Rowe Price Blue Chip Growth ETF | TCHP | May 15, 2024 | 36.29 | +1.65 |
T. Rowe Price Dividend Growth ETF | TDVG | May 15, 2024 | 38.42 | +0.90 |
T. Rowe Price Equity Income ETF | TEQI | May 15, 2024 | 40.05 | +0.53 |
T. Rowe Price Group | TROW | May 15, 2024 | 115.08 | +0.63 |
T. Rowe Price Growth Stock ETF | TGRW | May 15, 2024 | 34.88 | +1.51 |
T2 Biosystems | TTOO | May 15, 2024 | 5.97 | +43.51 |
Taboola.com | TBLA | May 15, 2024 | 4.34 | +0.23 |
Tactile Systems Technology | TCMD | May 15, 2024 | 13.69 | +0.44 |
Taitron Components A | TAIT | May 15, 2024 | 3.19 | +1.11 |
Taiwan Fund | TWN | May 15, 2024 | 40.10 | +1.52 |
Taiwan Index MSCI Ishares | EWT | May 15, 2024 | 51.31 | +1.79 |
Taiwan Semiconductor Manufacturing ADR | TSM | May 15, 2024 | 155.58 | +2.39 |
Take-Two Interactive Software | TTWO | May 15, 2024 | 148.08 | +2.15 |
Takeda Pharmaceutical ADR | TAK | May 15, 2024 | 13.39 | -0.45 |
TAL Education Group ADR | TAL | May 15, 2024 | 13.12 | -3.39 |
Talis Biomedical | TLIS | May 15, 2024 | 8.95 | +2.64 |
Talkspace | TALK | May 15, 2024 | 2.88 | +1.05 |
Talos Energy | TALO | May 15, 2024 | 12.14 | -1.14 |
Talphera | TLPH | May 15, 2024 | 1.22 | +19.12 |
Tandem Diabetes Care | TNDM | May 15, 2024 | 47.37 | +7.49 |
Tanger | SKT | May 15, 2024 | 28.29 | -2.14 |
Tango Therapeutics | TNGX | May 15, 2024 | 7.80 | +2.63 |
Tantech | TANH | May 15, 2024 | 0.54 | -2.15 |
Taoping | TAOP | May 15, 2024 | 0.72 | -2.05 |
Tapestry | TPR | May 15, 2024 | 42.67 | +1.33 |
Targa Resources | TRGP | May 15, 2024 | 115.58 | +1.01 |
Target | TGT | May 15, 2024 | 157.51 | -0.91 |
Target Global Acquisition I A | TGAA | May 15, 2024 | 11.30 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.